MarketPulse
I

$IPSEY

5 articles found
1 positive
2 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Genfit

GENFIT Advances ESG Agenda With B Corp Certification, 30+ Sustainability Initiatives

GENFIT earns B Corp certification and implements 30+ ESG initiatives, achieving 90% employee engagement and maintaining gender equality index of 88.
IPSEYsustainabilitybiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Genfit

GENFIT Advances ESG Agenda With B Corp Certification, 30 Sustainability Initiatives

GENFIT published 2025 extra-financial report, achieving B Corp certification and executing 30 ESG initiatives with strong employee engagement and gender equality metrics.
IPSEYsustainabilitybiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Unveils Early-Stage Immuno-Oncology Breakthroughs at AACR Congress

Ipsen presents preclinical data for two first-in-class cancer candidates targeting solid tumors and gastrointestinal cancers, advancing its immuno-oncology pipeline.
IPSEYantibody-drug conjugatesolid tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Withdraws Tazverik Globally While Reshuffling North America Leadership

Ipsen voluntarily withdraws Tazverik across all markets and appoints Michelle Werner as North America president, signaling strategic portfolio and leadership shifts.
IPSEYexecutive appointmentNorth America
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Withdraws Tazverik Drug Globally, Reshuffles North America Leadership

Ipsen withdraws Tazverik globally and appoints Michelle C. Werner as North America president, signaling strategic portfolio optimization and leadership strengthening.
IPSEYexecutive appointmentNorth America